TABLET LOSARTAN _ CHLORTHALIDONE
Nuclear Power Corporation of India Limited · Rajasthan · Pharmaceuticals · open
Key facts
- Published: 10 Aug 2026
- Closing date: 31 Aug 2026
- Status: open
- Department: Department of Atomic Energy
- Office: Rajasthan
Description
Tender for supply of various medicines including tablets, liquids, inhalers, injections, and creams with a total quantity of 15570 units, issued by the Department of Atomic Energy, Nuclear Power Corporation of India Limited, Rajasthan.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Supporting documents for relaxation from experience and turnover criteria
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (3)
- TABLET LOSARTAN CHLORTHALIDONE — Qty: 15570 unit
- TABLET OLANZAPINE
- LIQUID POVIDONE IODINE
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals